IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year debt growth rate
Latest
3.65%
↓ 84% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
22.50%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 3.65% |
| Q3 2025 | -32.18% |
| Q2 2025 | -15.13% |
| Q1 2025 | -40.05% |
| Q4 2024 | -9.98% |
| Q3 2024 | 30.47% |
| Q2 2024 | -2.87% |
| Q1 2024 | -8.42% |
| Q4 2023 | -9.09% |
| Q3 2023 | -7.32% |
| Q2 2023 | -6.24% |
| Q1 2023 | -6.60% |
| Q4 2022 | -5.50% |
| Q3 2022 | -6.03% |
| Q2 2022 | -5.07% |
| Q1 2022 | -4.83% |
| Q4 2021 | -4.18% |
| Q3 2021 | -3.87% |
| Q2 2021 | -35.16% |
| Q1 2021 | -1.92% |
| Q4 2020 | -1.79% |
| Q3 2020 | 1.36% |
| Q2 2020 | 76.44% |
| Q1 2020 | 1148.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -21.88% |
| Q4 2018 | -96.84% |
| Q3 2018 | -0.07% |
| Q2 2018 | -9.03% |
| Q1 2018 | -12.20% |
| Q4 2017 | -0.53% |
| Q3 2017 | 7.87% |
| Q2 2017 | -10.58% |
| Q1 2017 | -7.83% |
| Q4 2016 | 1.72% |
| Q3 2016 | 10.94% |
| Q2 2016 | -9.82% |
| Q1 2016 | -5.61% |